Listen Now

Topics Covered

  • Overview of Blood Cancers
  • New Research Presented at ASH
  • Disease-Specific Treatment Updates
  • Leukemia
  • Myeloproliferative Neoplasms (MPN)
  • Lymphoma
  • Multiple Myeloma
  • The Role of Precision Medicine & Clinical Trials
  • Talking with Your Health Care Team about Your Treatment Options
  • Quality-of-Life Concerns & Goals of Care
  • Questions for Our Panel of Experts

Our Panel of Experts

Michael J. Mauro, MD

Leader, Myeloproliferative Neoplasms Program, Member, Memorial Sloan Kettering Cancer Center, Professor of Medicine, Weill Cornell Medical College

John P. Leonard, MD

Richard T. Silver Distinguished Professor of Hematology and Medical Oncology, Associate Dean for Clinical Research, Weill Cornell Medicine, Associate Director, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, Executive Vice Chair, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine and New York-Presbyterian

Noopur Raje, MD

Director, Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Professor of Medicine, Harvard Medical School

Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop(pdf)(82.2 KB)

Workshop Date

This workshop was originally recorded on December 06, 2018.

Browse by Diagnosis

Browse by Topic

The information presented in this workshop is provided for your general information only. It is not intended as medical advice and should not be relied upon as a substitute for consultations with qualified health professionals who are aware of your specific situation. We encourage you to take information and questions back to your individual health care provider as a way of creating a dialogue and partnership about your cancer and your treatment.

Back to Top
Terms of Use and Privacy Policy

By using our website, you agree to our recently updated Privacy Policy . Here you will learn more about our use of cookies which help us make continuous improvements to our website. Learn more.